Prostate Cancer - Results from #24580

New treatment paradigm for prostate cancer: Abarelix initiation therapy for immediate testosterone suppression followed by a luteinizing hormone-releasing hormone agonist - Abstract December 20, 2011

African American men significantly underestimate their risk of having prostate cancer at the time of biopsy - Abstract December 20, 2011

Updating risk prediction tools: A case study in prostate cancer - Abstract December 20, 2011

BJUI Mini Reviews - Prostatic intraepithelial neoplasia: Its morphological and molecular diagnosis and clinical significance December 20, 2011

Antiangiogenic Thrombospondin-1 triggers cell migration and development of advanced prostate tumors December 19, 2011

Prognostic significance of neuroendocrine differentiation in prostate adenocarcinoma December 19, 2011

Pathological stage distribution in patients treated with radical prostatectomy reflecting the need for protocol-based active surveillance: Results from a contemporary European patient cohort - Abstract December 19, 2011

Effect of delaying surgery on radical prostatectomy outcomes: A contemporary analysis - Abstract December 19, 2011

From image-guided radiotherapy to dose-guided radiotherapy - Abstract December 19, 2011

The importance of an exponential prostate-specific antigen decline after external beam radiotherapy for intermediate risk prostate cancer - Abstract December 19, 2011

Alcohol consumption and prostate cancer risk: A meta-analysis of the dose-risk relation - Abstract December 19, 2011

GU Cancers Symposium 2012 - Novel Mechanisms and Therapies in Multidisciplinary Management - Program Announcement December 19, 2011

Prostate cancers detected by saturation repeat biopsy impairs the Partin tables' accuracy to predict final pathological stage - Abstract December 16, 2011

Value of prostate-specific antigen (PSA) mass ratio in the detection of prostate cancer in men with PSA levels of ≤ 10 ng/mL - Abstract December 16, 2011

Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy - Abstract December 16, 2011

Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies - Abstract December 16, 2011

Physician social networks and variation in prostate cancer treatment in three cities - Abstract December 16, 2011

Screening for prostate cancer by digital rectal examination and PSA determination in Senegal - Abstract December 16, 2011

The relationship between prostate volume and prostate-specific antigen variability: Data from the Baltimore Longitudinal Study of Aging and the Johns Hopkins Active Surveillance Program - Abstract December 16, 2011

Benefits, barriers, sources of influence, and prostate cancer screening among rural men - Abstract December 16, 2011

Page 1230 of 1335